Tamoxifen mechanically reprograms the tumor microenvironment via HIF-1A and reduces cancer cell survival.
Cortes E, Lachowski D, Robinson B, Sarper M, Teppo JS, Thorpe SD, Lieberthal TJ, Iwamoto K, Lee DA, Okada-Hatakeyama M, Varjosalo MT, Del Río Hernández AE.
Cortes E, et al. Among authors: lieberthal tj.
EMBO Rep. 2019 Jan;20(1):e46557. doi: 10.15252/embr.201846557. Epub 2018 Dec 11.
EMBO Rep. 2019.
PMID: 30538116
Free PMC article.